United States · Venture startup

Who invested in Expansion Therapeutics

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$6.9Mraised across 1 round since 2023, from 1 source

Latest round
Venture, $6.9MJan 2023
Investors
5
See who backed them

The rounds

  1. Jan 2023

Founders and team

From the SEC filings it signed: 1 on the team.

  • Renato SkerljExecutive Officer, Directori

On the board, as filediAndy PhillipsBeth SeidenbergLaura TadvalkarScott Rocklage

Everyone who backed them

Kleiner PerkinsVC firm1round
RA Capital ManagementPrivate equity1round
Cormorant Asset ManagementPrivate equity1round
5AM VenturesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Expansion Therapeutics

Who invested in Expansion Therapeutics?

Expansion Therapeutics's investors include Kleiner Perkins, RA Capital Management, Cormorant Asset Management, 5AM Ventures and Alexandria Venture Investments.

How much has Expansion Therapeutics raised?

Expansion Therapeutics has raised $6.9M across 1 round since 2023.

When did Expansion Therapeutics last raise?

Expansion Therapeutics's most recent round was a Venture of $6.9M in Jan 2023.

What was Expansion Therapeutics's biggest round?

Its most recent round, $6.9M in Jan 2023, is also its largest on record.

Who backed Expansion Therapeutics first?

Expansion Therapeutics's first round on record, in Jan 2023, was backed by Kleiner Perkins, RA Capital Management and Cormorant Asset Management and 2 others.

What stage is Expansion Therapeutics at?

Expansion Therapeutics's latest named round is a Venture, in Jan 2023.

Where is Expansion Therapeutics based?

Expansion Therapeutics is based in the United States.

Companies like Expansion Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.